TGA recommends continuation of AstraZeneca jab after blood-clotting case
- 3 years ago
The Therapeutic Goods Administration suggests moving forward with the AstraZeneca rollout despite a man developing clots in his liver, spleen and gut after receiving the jab. Queensland Vice President of the Australian Medical Association Dr Bav Manoharan says people should still have confidence in the vaccine.